2016
DOI: 10.1016/j.clbc.2015.11.005
|View full text |Cite
|
Sign up to set email alerts
|

Is Breast Conserving Therapy a Safe Modality for Early-Stage Male Breast Cancer?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
30
0
5

Year Published

2016
2016
2020
2020

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(38 citation statements)
references
References 20 publications
3
30
0
5
Order By: Relevance
“…Physical and emotive consequences of hormonal therapies and chemotherapies, including the fear for an emasculating therapy and sexual dysfunction, are more problematic than in the female counterpart, which limits their indications in male patients. As said by the recent literature [8], [11], [12], [16], [17] emerging BCS, in early stage MBC, has comparable survival rates to MRM and has been progressively more performed in the last years. Despite the current transition from radical to conservative surgical treatment of MBC, we retain that MRM is still regarded as the standard treatment due to the paucity of male breast tissue, the typical central sub-areolar location of the cancer with early nipple involvement and the debilitating side effects of adjuvant therapy necessary in BCS.…”
Section: Discussionmentioning
confidence: 86%
See 1 more Smart Citation
“…Physical and emotive consequences of hormonal therapies and chemotherapies, including the fear for an emasculating therapy and sexual dysfunction, are more problematic than in the female counterpart, which limits their indications in male patients. As said by the recent literature [8], [11], [12], [16], [17] emerging BCS, in early stage MBC, has comparable survival rates to MRM and has been progressively more performed in the last years. Despite the current transition from radical to conservative surgical treatment of MBC, we retain that MRM is still regarded as the standard treatment due to the paucity of male breast tissue, the typical central sub-areolar location of the cancer with early nipple involvement and the debilitating side effects of adjuvant therapy necessary in BCS.…”
Section: Discussionmentioning
confidence: 86%
“…According to Zaenger study, in the preliminary data collected from the European Organization for Research and Treatment of Cancer (EORTC) 56% of MBC patients had stage T1 cancer, but only 4% had undergone breast conservation surgery [12]. We report a case of MBC treatment and we extensively reviewed pertinent literature of the last 10 years to investigate whether BCS can be considered as the gold standard treatment, or if a more radical surgery is preferable.…”
Section: Introductionmentioning
confidence: 99%
“…The largest publication to date is a series evaluating the Surveillance, Epidemiology, and End Results (SEER) database for MBCs performed by Zaenger et al This report evaluated 6,263 men treated diagnosed with breast cancer from 1998 to 2011, and included 1777 men who had T1‐T2, node negative disease. Of this population, BCS was performed in 296 of these patients, with 135 (46%) of these patients receiving adjuvant radiation.…”
Section: Discussionmentioning
confidence: 99%
“…There are a few publications which evaluate disease free survival The largest publication to date is a series evaluating the Surveillance, Epidemiology, and End Results (SEER) database for MBCs performed by Zaenger et al 16 This report evaluated 6,263 men treated diagnosed with breast cancer from 1998 to 2011, and included 1777 men who had T1-T2, node negative disease.…”
Section: Discussionmentioning
confidence: 99%
“…More frequently patients undergo nipple reconstruction and tattooing to provide visual balance to the chest. Recent data published in 2016 shows that for early stage male breast cancer, breast conserving surgery yields comparable cause specific survival rates to modified radical mastectomy [13] , [14] , [15] , [16] , [17] . Such data may support a paradigm shift away from larger radical procedures, as was seen in female breast cancer over two decades ago.…”
Section: Discussionmentioning
confidence: 99%